Business Development in clinical research is in the process of a transition. The mounting costs of drug development and rationalizing of concerned departments is lashing many biotechnology and pharmaceutical companies to contract out clinical research programs. This is striking at the matching time as a tendency toward big pharma companies cementing chosen partnerships with a […]